Research projects
Start of main content
Intestinal inflammatory diseases: susceptibility and pharmacogenetic markers
14th national competition for scientific and technical research
Genetic and pharmacogenetic markers
Senior Researcher : María Elena Urcelay García
Research Centre or Institution : Hospital Universitario Clínico San Carlos. Madrid.
Abstract
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases of unknown causation. Both are considered multifactor autoimmune diseases, caused by environmental factors in patients with a genetic predisposition. Not only are there differences between the two, but each can also present very different clinical characteristics in different people, making them extremely heterogeneous. The main goal of this project is to identify the new genetic factors associated with the risk of developing inflammatory bowel diseases, by studying genes selected from candidates applying positional and functional criteria. By way of a case-control study with samples from 800 patients suffering from ulcerative colitis and Crohn's disease and 600 healthy control subjects, we will verify whether the different clinical forms of inflammatory bowel diseases correspond to a specific genetic makeup. That is, whether or not the disease develops in a specific way in the presence of a certain combination of susceptibility genes. The pharmacogenetics of the inflammatory bowel diseases will also be studied: the relationship between genetic determinants and response to the treatment and the appearance of adverse side effects. We hope, perhaps in the near future, that research into the relationship between the genotype and the clinical phenotype (anatomic location; how the disease reacts, both in the course it takes and its response to the different treatments; age of the patient when the disease commences; gender; etc.) will make it possible to predict the clinical progress, complications and prognosis of the disease, thus anticipating the natural course of inflammatory bowel diseases.
- Activities related
- Projects related
- News related
- Publications related
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
-
20
Apr
2023
Session Mujeres científicas en el ámbito farmacéutico Madrid, Thursday, 20 April 20223, 19:00 hours
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS) 2018 Senior Researcher : Antonio Artigas Raventós Research Centre or Institution : Instituto de Investigación e Innovación Parc Taulí (I3PT), Corporación Sanitaria i Universitaria Parc Taulí
- Risk Assesment of Bacterial Sepsis using multiomic and bioinformatics tools: an approach towards the Precision Medicine in Infectious Diseases 2018 Senior Researcher : María Teresa Coque González
- Extracellular vesicles biomarkers for the diagnosis and prognosis of post-surgical septic shock 2018 Senior Researcher : Eduardo Tamayo Gómez Research Centre or Institution : Hospital Clínico Universitario de Valladolid
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
-
José C. Clemente: "Buscamos cócteles de bacterias para reconstruir la microbiota"
Published on 04/20/2021
End of main content